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ABSTRACT 
Ulcerative colitis (UC) is a chronic immune-inflammatory disorder characterized by oxido-nitrosative stress, the 
release of pro-inflammatory cytokines and apoptosis. Ferulic acid (FA), a phenolic compound is considered to 
possess potent antioxidant, anti-apoptotic and anti-inflammatory activities. The aim is to evaluate possible 
mechanism of action of FA against trinitrobenzensulfonic acid (TNBS) induced ulcerative colitis (UC) in rats. 
UC was induced in Sprague-Dawley rats (150-200 g) by intrarectal administration of TNBS (100 mg/kg). FA 
was administered (10, 20 and 40 mg/kg, p.o.) for 14 days after colitis was induced. Various biochemical, 
molecular and histological changes were assessed in the colon. Intrarectal administration of TNBS caused 
significant induction of ulcer in the colon with an elevation of oxido-nitrosative stress, myeloperoxidase and 
hydroxyproline activity in the colon. Administration of FA (20 and 40 mg/kg) significantly decrease oxido-
nitrosative stress, myeloperoxidase, and hydroxyproline activities. Up-regulated mRNA expression of TNF-α, 
IL-1β, IL-6, COX-2, and iNOs, as well as down-regulated IL-10 mRNA expressions after TNBS administration, 
were significantly inhibited by FA (20 and 40 mg/kg) treatment. Flow cytometric analysis revealed that 
intrarectal administration of TNBS-induced significantly enhanced the colonic apoptosis whereas administration 
of FA (20 and 40 mg/kg) significantly restored the elevated apoptosis. FA administration also significantly 
restored the histopathological aberration induced by TNBS. The findings of the present study demonstrated that 
FA ameliorates TNBS-induced colitis via inhibition of oxido-nitrosative stress, apoptosis, proinflammatory 
cytokines production, and down- regulation of COX-2 synthesis. 
 
Graphical Abstract: TNBS 
caused activation of T cells which 
interact with CD40 on antigen 
presenting cells i.e. dendritic cells 
(DC) that induce the key Interleu-
kin 12 (IL-12)-mediated Th1 T cell 
immune inflammatory response. It 
releases interferon-γ (IFN-γ), 
which in turn induces macrophag-
es (MAC) to produce TNF-α and 
other pro-inflammatory cytokines 
(e.g., IL-1β, IL-6). This inflamma-
tory influx resulted in induction of 
ulcerative colitis (UC). Administra-
tion of FA may inhibit this IFN-γ 
induced inflammatory cascade via 
a decrease in the release of pro-
inflammatory cytokines to amelio-
rate TNBS-induced colitis. 
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INTRODUCTION 
Inflammatory bowel disease (IBD) is a 
chronic, relapsing, idiopathic clinico-
pathological condition where mucosal in-
flammation and hemorrhage lead to colonic 
damage (Andres and Friedman, 1999). Diar-
rhea and abdominal pain are the clinically 
discernible symptom of patients suffering 
from IBD. Ulcerative colitis (UC) and 
Crohn's disease (CD) are two debilitating 
and chronic disorders of gastrointestinal sys-
tem collectively referred as IBD. With in-
creased industrialization, the incidence and 
prevalence of IBD have surged worldwide 
affecting up to 0.5 % of the general popula-
tion. It has been reported that incidence of 
IBD has increased over a few decades rang-
ing from 10 to 30 per 100,000 (Kaplan, 
2015). Higher risk of colon cancer is 
associated with IBD patients besides signifi-
cantly decreased the quality of life.  
It has been well documented that an array 
of etiopathogenic factors including genetic 
modulation, infective agents, immunological 
disturbance, and smoking are the major risk 
factor for the development of IBD (Kandhare 
et al., 2016). Furthermore, altered pro-
inflammatory cytokines (tumour necrosis 
factor-α (TNF-α), interleukin (IL)), anti-
inflammatory cytokines (IL-4 and IL-10), 
glycosaminoglycan content in gastric muco-
sa, increased oxidative stress and intestinal 
permeability are the important hallmark of 
IBD (Kandhare et al., 2012c). Evidence from 
the previous studies suggested that gastroin-
testinal (GI) tract is more susceptible to 
damage induced by oxidants (Kandhare et 
al., 2013; Kumar et al., 2014). It may result 
from repetitive exposure of gastric mucosa to 
various stresses that increased interaction of 
immune cells, dietary factors, and intestinal 
flora in the GI tract.  
An array of animal models of experi-
mental colitis has been employed to evaluate 
the potential of various therapeutic moieties 
against IBD. Among all animal models of 
IBD, 2,4,6- trinitrobenzene sulfonic acid 
(TNBS)-induced colitis is well established, 
easily induced and highly reproducible 
model that mimics most of the clinico-
pathological symptoms of ulcerative colitis 
(de Faria et al., 2012; Kandhare et al., 2011; 
Randhawa et al., 2014). When TNBS is 
delivered intra-rectally, the immunological 
inflammation results from a formation of co-
valent binding of haptenates autologous co-
lonic proteins with a trinitrophenyl moiety 
which induces an IL-12-mediated Th1 T cell 
transmural colitis, a delayed-type hypersen-
sitivity (Hoffmann et al., 2002). This IL-12-
mediated Th1 T cell transmural colitis has 
resemblance with human IBD in many fea-
tures including histological and immunologi-
cal alterations (Randhawa et al., 2014). 
The current clinical practice guidelines 
indicate that IBD should be treated using 5-
aminosalicylic acid (5-ASA), sulfasulfa-
pyridine (SASP), broad spectrum antibiotics, 
steroids, and immunosuppressant. These in-
terventions inhibit the inflammatory media-
tors via various mechanisms leading to 
downregulation of the immune and inflam-
matory responses of IBD (Kandhare et al., 
2013). However, these treatment strategies 
are associated with adverse effects (such as 
nausea and vomiting, skin rashes, hepatitis, 
hematologic abnormalities, folate deficiency, 
pancreatitis, systemic lupus erythematosus, 
etc.) and high relapse rate that limit their 
clinical usage (Joshi et al., 2005). Hence, 
there is an inevitable need to develop a 
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therapeutic strategy which overcomes these 
adverse events. Herbal drugs provide a ray of 
hope in the development of novel and thera-
peutically acceptable drugs with limited ad-
verse reaction profile. Few systematic re-
views of randomized control trials have 
found herbal drugs as a promising therapy 
for the treatment of IBD (Ng et al., 2013; 
Triantafyllidi et al., 2015). Moreover, most 
of the published trials showed no side ef-
fects. In fact, the number and type of side 
effects were similar to those of placebo or 
mesalazine. It is quite important in patients 
with previous operations or patients who ex-
perienced significant side effects being on 
conventional treatment. Hence, larger con-
trolled studies with stricter endpoints and 
better-defined patient groups are required to 
obtain more conclusive results on the use of 
Complementary and Alternative Medicine 
(CAM) therapies in IBD. In the light of the 
experimental evidence, it is assumed that 
novel herbal moieties are explored as possi-
ble drug candidates/pharmacophores. 
Polyphenols are chemical moieties pre-
sent abundantly in various natural com-
pounds. These compounds are well-estab-
lished antioxidants with excellent free radical 
quenching ability, and play an important role 
in amelioration of various immune-inflam-
matory diseases which including arthritis, al-
lergic rhinitis, asthma and IBD (Vauzour et 
al., 2010). Ferulic acid (4-hydroxy-3-metho-
xycinnamic acid), a polyphenolic compound 
present abundantly in various natural plants 
including rice, wheat, oats, pineapple, grass-
es, grains, vegetables, flowers, fruits, leaves, 
beans, seeds of coffee, artichoke, peanut and 
nuts (Kumar and Pruthi, 2014). Moreover, 
cell walls of cereal grains and a variety of 
food plants (pineapple, bananas, spinach, and 
beetroot) contain extractable amount (0.5-
2 %) of FA, and highest known 
concentration of ferulic acid (FA) glucoside 
has been found in flax seed (4.1 ± 0.2 g/kg) 
(Besseau et al., 2007; Kumar and Pruthi, 
2014). FA possesses a plethora of pharmaco-
logical properties such as antioxidant, free 
radicals scavenger, anticancer, antihyper-
lipidemic, antihypertensive, antidiabetic, an-
timicrobial, radioprotective, cardioprotective, 
neuroprotective, anti-carcinogenic and hepa-
toprotective potential (Baskaran et al., 2010; 
Bourne and Rice-Evans, 1998). In addition, 
FA inhibits the expression of cytotoxic en-
zymes such as cyclooxygenase-2 (Ojha et al., 
2015). The resonance stabilization ability of 
FA is mainly responsible for its antioxidant 
and anti-inflammatory activity in carragee-
nan-induced rat paw edema model (Chawla 
et al., 1987). Earlier studies have suggested 
that FA protects brain cells through inhibi-
tion of hydroxyl and peroxyl radicals 
(Kanski et al., 2002; Ogiwara et al., 2001). 
FA has the ability to promote healing via in-
hibition of lipid peroxidation and nitric oxide 
synthase (Ghaisas et al., 2014). The previous 
study has shown that Brazilian Green Propo-
lis possesses antiulcer potential mainly due 
to the presence of FA in it (Barros et al., 
2008). However, its therapeutic activity 
against TNBS-induced IBD has not been 
experimentally evaluated. Thus, the aim of 
present investigation was to evaluate the po-
tential of FA against TNBS-induced experi-
mental colitis in laboratory animals by inves-
tigating various biochemical, molecular and 
histological changes. 
 
MATERIAL AND METHODS 
Animals 
Adult Sprague Dawley rats (150-200 g) 
were obtained from the National Institute of 
Biosciences, Pune, India. They were 
maintained at 24 ± 1° C, with a relative hu-
midity of 45-55 % and 12:12 h dark/light cy-
cle. The animals had free access to standard 
pellet chow (Pranav Agro Industries Ltd., 
Sangli, India) and water throughout the ex-
perimental protocol. All experiments were 
carried out between 09:00 and 17:00 h. The 
experimental protocol was approved by the 
Institutional Animal Ethics Committee 
(IAEC) of Poona College of Pharmacy, Pune 
and performed in accordance with the guide-
lines of Committee for Control and Supervi-
sion of Experimentation on Animals 
(CPCSEA). 
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Drugs and chemicals 
Ferulic acid and TNBS were purchased 
from Sigma Chemical Co. (St Louis, MO, 
USA). Sulfasalazine was obtained as a gift 
sample from Symed Pharmaceutical Pvt. 
Ltd., Hyderabad. Total RNA Extraction kit 
and One-step Reverse transcription-poly-
merase chain reaction (RT-PCR) kit was 
purchased from MP Biomedicals India Pri-
vate Limited, India. 
 
Induction of colitis and drug treatment 
schedule 
Colitis was induced according to the pro-
cedure described elsewhere (Li et al., 2011). 
Briefly, rats were slightly anaesthetized with 
ether following a 24 h fast, and then TNBS 
dissolved in 50 % ethanol was instilled into 
the colon of the animals (100 mg in a 
volume of 0.25 mL) using a medical-grade 
polyurethane catheter for enteral feeding 
(external diameter 2 mm) inserted 8 cm into 
the anus. Different control groups were 
created for comparison with TNBS/ethanol 
instillation: rats in the sham, as well as 
ethanol, treated group received an enema of 
physiological saline instead of the TNBS so-
lution, and ethanol treated group received 
0.25 mL of 50 % ethanol. Rats were random-
ly divided into following groups of 10-12 
rats as follows:  
Group I Sham Control: Received physio-
logical saline in a volume of 0.25 
mL (once, intra-rectally) and 1 
ml of 1 % aqueous solution of 
Dimethyl sulfoxide (DMSO) for 
14 days 
Group II Ethanol treated animals: Re-
ceived ethanol (50 %) in a vol-
ume of 0.25 mL (once, intra-
rectally) and 1 ml of 1 % aque-
ous solution of DMSO for 14 
days 
Group III TNBS-induced control animals: 
Received TNBS (100 mg/kg) in 
a volume of 0.25 mL (once, in-
tra-rectally) and 1 ml of 1 % 
aqueous solution of DMSO for 
14 days 
Group IV TNBS-induced and Sulfasalazine 
(50 mg/kg) treated animals: Re-
ceived TNBS (100 mg/kg) in a 
volume of 0.25 mL (once, intra-
rectally) and treatment with sul-
fasalazine (50 mg/kg, p.o.) 14 
day  
Group V TNBS-induced and Ferulic acid 
(10 mg/kg) treated animals: Re-
ceived TNBS (100 mg/kg) in a 
volume of 0.25 mL (once, intra-
rectally) and treatment with FA 
(10 mg/kg, p.o.) 14 day 
Group VI TNBS-induced and Ferulic acid 
(20 mg/kg) treated animals: Re-
ceived TNBS (100 mg/kg) in a 
volume of 0.25 mL (once, intra-
rectally) and treatment with FA 
(20 mg/kg, p.o.) 14 day 
Group VII TNBS-induced and Ferulic acid 
(40 mg/kg) treated animals: Re-
ceived TNBS (100 mg/kg) in a 
volume of 0.25 mL (once, intra-
rectally) and treatment with FA 
(40 mg/kg, p.o.) 14 day 
The details of the experimental paradigm 
are presented in the Supplementary File 1. 
The selection of dose for FA was based on 
the studies carried out by the previous re-
searcher (Balasubashini et al., 2004). FA 
(1 % aqueous solution of DMSO) was 
administered to rats in the three different 
dosages (10, 20 and 40 mg/kg, p.o., once a 
day) for 14 consecutive days. Sulfasalazine 
(1 % aqueous solution of DMSO) was given 
in a dose of 50 mg/kg/day orally in rats 
(Hyam et al., 2013). On the 15th day, rats 
were sequentially anesthetized with 
anesthetic ether for about 30-40 s. The blood 
was withdrawn by retro-orbital puncture. 
Each blood sample was collected into sepa-
rate vials for determination of serum parame-
ters. After blood collection, the animals were 
sacrificed by cervical dislocation; the colon 
was excised then assessment of colonic dam-
age was performed and frozen immediately 
in liquid nitrogen and stored at -80° C for 
further biochemical (n = 5) and molecular 
examination (n = 4). A part of the freshly ex-
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cised colon of three animals from each group 
was washed with saline and preserved in 
10 % formaldehyde solution for histopatho-
logical studies. 
 
Assessment of colonic damage, ulcer area 
and ulcer index 
The severity of colitis was evaluated by 
an independent observer who was blinded to 
the treatment. For each animal, the distal 
10 cm portion of the colon was removed and 
cut longitudinally, slightly cleaned in physio-
logical saline to remove fecal residues and 
weighed. Macroscopic inflammation scores 
were assigned based on clinical features of 
the colon. The presence of adhesions (score 
0-10) and stool consistency (score 0-4) were 
evaluated according to the previously report-
ed methods (Kandhare et al., 2013; Kumar et 
al., 2014). Ulcer area and ulcer index were 
assessed according to previously reported 
methods (Kandhare et al., 2013; Kumar et 
al., 2014). 
 
Biochemical assays 
For colon homogenization, tissue seg-
ments were mixed with 0.1 M phosphate 
buffer and homogenized on ice for 60 sec at 
10000 r.p.m. in a homogenizer (Remi 
Equipment Pvt. Ltd., Remi Motors Ltd., 
Mumbai, India). Supernatant of tissue ho-
mogenates was employed to estimate super-
oxide dismutase (SOD), reduced glutathione 
(GSH), lipid peroxidation (MDA activity) 
and nitric oxide (NO activity) as described 
previously (Kandhare et al., 2013; Kumar et 
al., 2014). The colonic myeloperoxidase as-
say and hydroxyproline activity were 
determined according to the previously de-
scribed method (Kandhare et al., 2013; 
Kumar et al., 2014). 
 
RNA extraction and RT-PCR analysis 
The levels of mRNA were analyzed in 
colon tissue using RT-PCR. Single-stranded 
cDNA was synthesized from 5 μg of total 
cellular RNA using reverse transcriptase kit 
(MP Biomedicals India Private Limited, In-
dia) as described previously (Kandhare et al., 
2012a). The primer sequence for tumor ne-
crosis factor-α (TNF-α), Interleukin-1β (IL-
1β), Interleukin-6 (IL-6), Interleukin-10 (IL-
10), Cyclooxygenase-2 (COX-2), inducible 
nitric oxide synthase (iNOs), and β-actin are 
presented in the Supplementary File 2. Am-
plification of β-actin served as a control for 
sample loading and integrity. PCR products 
were detected by electrophoresis on a 1.5 % 
agarose gel containing ethidium bromide. 
The size of amplicons was confirmed using a 
100-bp ladder as a standard size marker. The 
amplicons were visualized, and images were 
captured using a gel documentation system 
(Alpha Innotech Inc., San Leandro, CA, 
USA). Expression of all the genes was as-
sessed by generating densitometry data for 
band intensities in different sets of experi-
ments and was generated by analyzing the 
gel images on the Image J software (Version 
1.33, Wayne Rasband, NIH, Bethesda, MD, 
USA) semi-quantitatively. The band intensi-
ties were compared with constitutively ex-
pressed β-actin. The intensity of mRNAs 
was standardized against that of the β-actin 
mRNA from each sample, and the results 
were expressed as PCR-product/ β-actin 
mRNA ratio. 
 
Flow cytometry analysis 
Preparation of lamina propria mononu-
clear cell (LPMC) suspensions and determi-
nation of apoptotic cell populations were de-
termined as previously described (Kandhare 
et al., 2012a). At the end of treatment, the 
colon of rats was collected and mixed with 
0.4 % collagenase and 0.25 % Trypsin at 
37° C for 30 min and dissociated, grinded 
and obtained homogenate was passed 
through a 70 μm nylon mesh. LPMC suspen-
sion was washed three times with phosphate-
buffered saline (PBS). In order to determine 
LPMC apoptosis, the isolated LPMCs were 
incubated with rabbit anti-cow S-100 anti-
body and followed by staining with APC-
goat anti-rabbit IgG (both from BD) with 
FITC-Annexin V and PI (Sigma-Aldrich, St. 
Louis, MO, USA). The percentages of ex-
pression of Fas and Annexin-V on gated S-
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100 positive LPMC were analyzed by a 
Fluorescence-activated cell sorting (FACS) 
Calibur cytometer using CELL Quest soft-
ware (Becton & Dickinson, San Diego, 
USA). 
 
Evaluation based on microscopic  
(histologic) characters 
Freshly excised colon of three animals 
from each group was washed with saline and 
preserved in 10 % formaldehyde solution for 
histopathological studies. The specimens 
were dehydrated and placed in xylene for 1 
hour (3 times) and later in ethyl alcohol 
(70 %, 90 %, and 100 % respectively) for 2 
hours. Then paraffin-embedded tissue sec-
tions cut at five μm thickness were prepared 
and stained after deparaffination using hema 
toxylin and eosin stain (H & E). Sections 
were examined under a light microscope (an 
optical microscope with Nikon E200 cam-
era) to obtain a general impression of the his-
topathology features of a specimen such as 
thickening of the mucosa, destruction of mu-
cosal epithelium, inflammatory cell infiltra-
tion, submucosal edema, necrosis and ulcera-
tion (Kandhare et al., 2013). Photomicro-
graphs were captured at a magnification of 
40 X and 100 X.  
 
Statistical analysis 
All the results were expressed as mean ± 
S.E.M. Data analysis was performed using 
GraphPad Prism 5.0 software (GraphPad, 
San Diego, CA). Statistical comparisons 
were made between drug-treated groups and 
TNBS control animals. Data analyzed using 
one-way ANOVA followed by Tukey's mul-
tiple range test. Data of macroscopical score 
and stool consistency score was analyzed us-
ing nonparametric Kruskal–Wallis ANOVA. 
A value of P < 0.05 was considered to be 
statistically significant. 
 
RESULTS 
Effect of FA on TNBS-induced alteration 
in body weight, colon weight to length ratio, 
ulcer area, ulcer index, macroscopic scores 
and stool consistency 
There was significant decrease (p < 0.05) 
in the body weight whereas colon weight to 
length ratio, macroscopic scores, and stool 
consistency score were significantly in-
creased (p < 0.05) in TNBS-induced control 
rats as compared to sham as well as ethanol 
treated rats. Intra-rectal instillation of TNBS 
significantly increased (p < 0.05) the ulcer 
area and ulcer index in TNBS-induced con-
trol rats as compared to sham as well as 
ethanol treated rats. When compared with 
TNBS-induced control rats, treatment with 
FA (20 and 40 mg/kg) showed significant 
inhibition (p < 0.05) in TNBS-induced alter-
ations in body weight, colon weight to length 
ratio, macroscopic scores, and stool con-
sistency. However, FA (20 and 40 mg/kg) 
treatment significantly decreased (p < 0.05) 
ulcer area and index compared to TNBS-
induced control rats. Treatment with sul-
fasalazine (350 mg/kg) also significantly in-
creased (p < 0.05) body weight and signifi-
cantly decreased (p < 0.05) colon weight to 
length ratio, macroscopic scores and stool 
consistency score as compared to TNBS-
induced control rats. When compared with 
TNBS-induced control rats, sulfasalazine 
(350 mg/kg) treated rats also showed signifi-
cant amelioration (p < 0.05) of increased ul-
cer area and ulcer index. Moreover, in-
creased body weight as well as decreased in 
colon weight to length ratio, macroscopic 
scores, and stool consistency score was more 
significant (p < 0.05) in sulfasalazine (350 
mg/kg) treated rats as compared to FA (10 
and 20 mg/kg) treated rats. When compared 
with FA (20 mg/kg) treatment, FA (40 mg/ 
kg) significantly (p < 0.05) restore the al-
tered ulcer area, ulcer index, macroscopic 
scores, and stool consistency (Table 1). 
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Effect of FA on TNBS-induced alteration 
in oxido-nitrosative stress 
The colonic SOD and GSH levels were 
significantly decreased (p < 0.05) while co-
lonic MDA and NO levels were significantly 
increased (p < 0.05) in TNBS-induced con-
trol rats after intrarectal administration of 
TNBS as compared to sham as well as 
ethanol treated rats. Administration of FA 
(10 mg/kg) failed to show any significant 
changes in increased oxido-nitrosative stress 
as compared to TNBS-induced control rats. 
However, FA (20 and 40 mg/kg) treatment 
significantly increased (p < 0.05) the levels 
of colonic SOD and GSH; whereas signifi-
cantly decreased (p < 0.05) the colonic MDA 
and NO levels as compared to TNBS-
induced control rats. When compared with 
TNBS-induced control rats, sulfasalazine 
(350 mg/kg) treatment also significantly re-
stored (p < 0.05) in the TNBS-induced alter-
ations in oxido-nitrosative stress. Moreover, 
sulfasalazine administration significantly de-
creased (p < 0.05) the colonic oxido-nitrosa-
tive stress as compared to FA (20 and 40 
mg/kg) treated rats (Table 2). 
 
Effect of FA on TNBS-induced alteration 
in colonic MPO and hydroxyproline activity 
There was a significant increase (p < 0.05) in 
colonic MPO and hydroxyproline activity in 
TNBS-induced control rats as compared to 
sham as well as ethanol treated rats. FA (20 
and 40 mg/kg) treatment significantly de-
creased (p < 0.05) the colonic MPO and hy-
droxyproline activity as compared to TNBS-
induced control rats. However, there was 
non-significant decreased in colonic MPO 
and hydroxyproline activity in FA (20 and 
40 mg/kg) treated rats as compared to 
TNBS-induced control rats. When compared 
with TNBS-induced control rats, sulfasala-
zine (350 mg/kg) treatment also showed the 
significant decrease (p < 0.05) in colonic 
MPO and hydroxyproline activity (Table 2). 
 
Effect of FA on TNBS-induced alteration 
in colonic TNF-α, IL-1β, IL-6, and IL-10 
mRNA expressions 
Intra-rectal instillation of TNBS signifi-
cantly upregulated (p < 0.05) colonic TNF-α, 
IL-1β, and IL-6, mRNA expression and co-
lonic IL-10 mRNA expression was down-
regulated significantly (p < 0.05) in TNBS-
induced control rats as compared to sham as 
well as ethanol treated rats. Upregulated 
TNF-α, IL-1β and IL-6 mRNA expressions 
were significantly down-regulated (p < 0.05) 
by FA (20 and 40 mg/kg) treatment whereas 
IL-10 mRNA expression was significantly 
upregulated (p < 0.05) by FA (20 and 40 mg/ 
kg) treatment as compared to TNBS-induced 
control rats. On the other hand, FA (10 mg/ 
kg) treatment failed to show a significant ef-
fect on TNBS-induced changes on colonic 
mRNA expressions of TNF-α, IL-β, and IL-6 
levels. Furthermore, sulfasalazine (350 mg/ 
kg) treatment showed the significantly 
down-regulated (p < 0.05) colonic TNF-α, 
IL-1β, and IL-6 mRNA expression while 
significantly up-regulated (p < 0.05) colonic 
IL-10 mRNA expression as compared to 
TNBS-induced control rats. Moreover, up-
regulation of colonic IL-10 mRNA expres-
sion by FA (40 mg/kg) treatment was signif-
icant (p < 0.05) as compared to sulfasalazine 
(350 mg/kg) treatment. Furthermore, treat-
ment with FA (40 mg/kg) showed significant 
(p < 0.05) down-regulation in TNF-α and IL-
1β mRNA expression as compared to FA (20 
mg/kg) treatment (Figure 1). 
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Table 1: Effect of FA on TNBS-induced alterations in body weight, colon weight to length ratio, ulcer area, ulcer index, macroscopic score and stool 
consistency score in rats 
Treatment Body Weight (gm) 
Colon weight 
to length ratio 
Ulcer area 
(mm2) Ulcer index 
 % Inhibi-
tion 
Macroscopic 
score 
Stool Con-
sistency 
Score 
Sham 225.81 ± 3.84 0.14 ± 0.002 0.00 ± 0.00 0.00 ± 0.00 --- 0.00 ± 0.00 0.40 ± 0.24 
Ethanol treated 220.77 ± 4.78 0.13 ± 0.004 0.00 ± 0.00 0.00 ± 0.00 --- 0.00 ± 0.00 0.40 ± 0.24 
TNBS-induced Control 178.22 ± 2.78# 0.24 ± 0.007# 36.41 ± 2.44# 72.45 ± 4.78# --- 7.40 ± 0.20# 3.60 ± 0.37# 
TNBS + Sulfasalazine (350) 221.22 ± 3.78*,$ 0.11 ± 0.006*,$ 4.78 ± 0.42*,$ 5.96 ± 1.11*,$ 91.78 2.40 ± 0.50*,$ 1.40 ± 0.24*,$ 
TNBS + FA (10) 187.22 ± 4.85 0.21 ± 0.006 31.52 ± 1.78 62.48 ± 3.33 13.76 6.40 ± 0.37 3.20 ± 0.37 
TNBS + FA (20) 208.44 ± 2.84* 0.16 ± 0.007* 25.63 ± 2.77*,$ 34.01 ± 2.77*,$ 53.05 4.60 ± 0.50* 2.40 ± 0.24 
TNBS + FA (40) 218.74 ± 3.44*,$ 0.14 ± 0.003*,$ 12.74 ± 1.17*,$ 8.78 ± 2.22*,$ 87.88 3.40 ± 0.37*,$ 1.40 ± 0.24*,$ 
Data are expressed as mean ± S.E.M. (n = 5) and analyzed by one-way ANOVA followed by Tukey's multiple range test. Data of macroscopical score and stool consistency was analyzed using  
nonparametric Kruskal–Wallis ANOVA followed by Tukey's multiple range test.  
*P < 0.05 as compared to TNBS-induced control group, #P < 0.05 as compared to sham as well as ethanol-treated control group and $P < 0.05 as compared to one another. 
 
 
Table 2: Effect of FA on TNBS-induced alterations in colonic SOD, GSH, MDA, NO, MPO and hydroxyproline activity in rats 
Treatment Colonic SOD (U/mg of protein)
Colonic GSH 
(µg/mg protein) 
Colonic MDA 
(nM/mg of pro-
tein) 
Colonic NO 
(µg/ml) 
Colonic MPO 
(U/mg) 
Colonic hydrox-
yproline (µg/mg 
tissue) 
Sham 11.48 ± 1.45 3.15 ± 0.70 1.22 ± 0.22 24.63 ± 2.22 4.78 ± 0.55 422.78 ± 32.51 
Ethanol treated 10.22 ± 2.23 2.89 ± 0.42 1.78 ± 0.41 28.27 ± 1.78 5.01 ± 0.38 487.99 ± 51.52 
TNBS-induced Control 2.48 ± 0.55# 0.41 ± 0.09# 5.78 ± 1.11# 78.45 ± 3.96# 18.78 ± 1.63# 1472.3 ± 87.96# 
TNBS + Sulfasalazine (350) 9.11 ± 0.44*,$ 2.78 ± 0.88*,$ 2.47 ± 0.55*,$ 40.40 ± 2.88*,$ 6.22 ± 0.78*,$ 859.63 ± 55.74*,$
TNBS + FA (10) 3.72 ± 0.22 0.58 ± 0.22 4.92 ± 1.04 65.84 ± 3.44 17.62 ± 1.20 1214.12 ± 77.65 
TNBS + FA (20) 5.48 ± 1.11*,$ 1.62 ± 0.47*,$ 3.24 ± 0.85*,$ 51.41 ± 3.22*,$ 12.45 ± 3.11*,$ 884.62 ± 44.15*,$
TNBS + FA (40) 7.25 ± 1.04*,$ 2.40 ± 0.98*,$ 2.95 ± 0.70*,$ 45.77 ± 2.12*,$ 9.78 ± 1.52*,$ 654.78 ± 50.12*,$
Data are expressed as mean ± S.E.M. (n = 5) and analyzed by one-way ANOVA followed by Tukey's multiple range test.  
*P < 0.05 as compared to TNBS-induced control group, #P < 0.05 as compared to sham as well as ethanol-treated control group and $P < 0.05 as compared to one another. 
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Figure 1: Effect of FA on TNBS-induced alteration in colonic TNF-α, IL-1β, IL-6, IL-10, COX-2 and 
iNOs mRNA expression in rats (A), quantitative representation of mRNA expression of TNF-α (B), IL-
1β (C), IL-6 (D), IL-10 (E), COX-2 (F) and iNOs (G). Data are expressed as mean ± SEM (n = 4) and 
analyzed by one-way ANOVA followed by Tukey's multiple range test.  
*p < 0.05 as compared to the TNBS-induced control group, #p < 0.05 as compared to sham as well as 
ethanol-treated control group and $p < 0.05 as compared to one another. SLZ (350): TNBS-induced 
and Sulfasalazine (350 mg/kg, p.o.) treated group; FA (10): TNBS-induced and Ferulic acid (10 mg/kg, 
p.o.) treated group; FA (20): TNBS-induced and Ferulic acid (20 mg/kg, p.o.) treated group and FA 
(40): TNBS-induced and Ferulic acid (40 mg/kg, p.o.) treated group. Lane 1: Ladder 1000 bp, Lane 2: 
mRNA expression of sham group, Lane 3: mRNA expression of ethanol-treated control group, Lane 4: 
mRNA expression of TNBS-induced control group, Lane 5: mRNA expression of TNBS-induced and 
sulfasalazine (350 mg/kg, p.o.) treated group, Lane 6: mRNA expression of TNBS-induced and FA (10 
mg/kg, p.o.) treated group, Lane 7: mRNA expression of TNBS-induced and FA (20 mg/kg, p.o.) 
treated group and Lane 8: mRNA expression of TNBS-induced and FA (40 mg/kg, p.o.) treated group. 
 
 
Effect of FA on TNBS-induced alteration 
in colonic COX-2 and iNOs mRNA expres-
sions 
There was significant upregulation (p < 
0.05) in colonic COX-2 and iNOs mRNA 
expressions in TNBS-induced control rats af-
ter intrarectal administration of TNBS as 
compared to sham as well as ethanol treated 
rats. FA (20 and 40 mg/kg) treatment signifi-
cantly down-regulated (p < 0.05) colonic 
COX-2 and iNOs mRNA expressions as 
compared to TNBS-induced control rats. 
However, FA (10 mg/kg) treatment failed to 
show any significant down-regulation in co-
lonic COX-2 and iNOs mRNA expressions 
as compared to TNBS control rat. When 
compared with TNBS control rats, sulfasala-
zine (350 mg/kg) treatment also showed the 
significant down-regulation (p < 0.05) of co-
lonic COX-2 and iNOs mRNA expression. 
Whereas, this down-regulation in the colonic 
COX-2 mRNA expression was more signifi-
cant (p < 0.05) in the FA (40 mg/kg) treated 
rats than sulfasalazine (350 mg/kg) treated 
rats. FA (40 mg/kg) treatment showed signif-
icant (p < 0.05) down-regulation in colonic 
COX-2 mRNA expressions as compared to 
FA (20 mg/kg) treatment (Figure 1). 
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Effect of FA on TNBS-induced alteration 
in colonic apoptosis 
There was a significant increase (p < 
0.05) in the colonic apoptosis of TNBS-
induced control rats as compared to sham as 
well as ethanol treated rats. When compared 
to TNBS-induced control rats, treatment with 
FA (20 and 40 mg/kg) significantly de-
creased (p < 0.05) the colonic apoptosis. FA 
(10 mg/kg) treatment showed non-significant 
down-regulation in colonic apoptosis as 
compared to TNBS-induced control rats. 
However, sulfasalazine (350 mg/kg) treat-
ment significantly decreased (p < 0.05) the 
colonic apoptosis when compared to TNBS-
induced control rats. Furthermore, decreased 
in colonic apoptosis was more significant (p 
< 0.05) in sulfasalazine (350 mg/kg) treated 
rats as compared to FA-treated rats (Figure 
2). 
 
Effect of FA on histological alteration  
Figure 3A and Figure 3B depicted the 
normal architecture of colon tissue from 
sham as well as ethanol treated rat which is 
devoid of any inflammatory infiltration ne-
crosis and edema. Intra-rectal instillation of 
TNBS caused significant elevation (p < 0.05) 
in inflammatory response characterized by 
thickening of the mucosa, extensive 
destruction of mucosal epithelium, inflam-
matory cell infiltration with necrotic foci, 
submucosal edema, loss of mucus-secreting 
cells, necrosis and ulcer on the mucosal 
surface (figure 3C). Rats treated with FA (20 
and 40 mg/kg) showed significant inhibition 
(p < 0.05) in TNBS-induced colonic histo-
logical damage which was characterized by 
significant reduction in the inflammatory in-
filtrate as well as mucosal thickening. FA 
showed the mild depletion of goblet cell. FA 
also showed the significant reduction (p < 
0.05) of mucosal epithelium destruction, ne-
crosis, ulceration and submucosal edema 
thus re-epithelialization of surface area (Fig-
ure 3E and Figure 3F). The section of colon 
from sulfasalazine (350 mg/ kg) treated rats 
showed a significant decrease (p < 0.05) in 
inflammatory infiltration, edema, and ulcera-
tion (Figure 3D and Table 3). 
 
DISCUSSION 
Ulcerative colitis is an inflammatory 
bowel disease that represents clinico-
pathologic features of inflammation of co-
lonic mucosa. Several lines of evidence 
suggested evidence that imbalance in the 
mucosal immune system caused generation 
of inflammatory mediators such as reactive 
oxygen species (ROS) and cytokines (TNF, 
IL-1Β, and IL-6) which in turn leads to 
chronic inflammation, ulceration and lesions 
of the colonic mucosa, and morphologically 
represented as leukocyte infiltration, edema, 
and tissue injury (Kandhare et al., 2012c). 
TNBS-induced experimental colitis is a sim-
ple, reliable, reproducible, robust model 
widely used for screening of potential drug 
candidates for IBD (de Faria et al., 2012; 
Kandhare et al., 2011; Randhawa et al., 
2014). Intracolonic administration of an in-
flammatory or haptenizing agent like TNBS 
caused delayed-type hypersensitivity result-
ed in IL-12-mediated Th1 T cell transmural 
colitis which permits examination of effects 
of various agents with potent immune-
inflammatory inhibitory activity (Randhawa 
et al., 2014). In the present study, we have 
investigated the ameliorative effect of FA in 
the rat model of TNBS-induced colitis by as-
sessing various biochemicals, molecular and 
histological changes.  
In the past, researchers have underlined 
the correlation between the pathogenesis of 
ulcerative colitis with oxidative stress in the 
both preclinical (Keshavarzian et al., 1990) 
as well as clinical settings (D'Odorico et al., 
2001). It has been reported that activated 
phagocytic leukocytes have an ability to pro-
duce superoxide radicals that eventually 
leads to the production of reactive hydroxyl 
radical and peroxide (Adil et al., 2014; 
Aswar et al., 2015). Administration of TNBS 
may disrupt the endogenous antioxidant de-
fense system leading to colonic oxidative 
damage (Li et al., 2011). Superoxide dis-
mutase (SOD) is an endogenous enzyme, 
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Figure 2: Effect of FA on TNBS-induced alteration in percent apoptosis (A-F). A representative image 
of apoptotic cell populations from sham group (A), ethanol-treated control group (B), TNBS-induced 
control group (C), TNBS-induced and Sulfasalazine (350 mg/kg, p.o.) treated group (D), TNBS-
induced and FA (20 mg/kg, p.o.) treated group (E) and TNBS-induced and FA (40 mg/kg, p.o.) treated 
group (F) observed after FACS analysis using Annexin V/FITCPI stain. Four distinct cell distribution 
patterns are visible: normal viable cells (lower left quadrant), early apoptotic cells (lower right quad-
rant), necrotic cells (upper right quadrant and upper left quadrant). A quantitative representation of FA 
effect on TNBS-induced alteration in percent apoptosis (G). Data are expressed as mean ± SEM 
(n = 4) and analyzed by one-way ANOVA followed by Tukey's multiple range test.  
*p < 0.05 as compared to the TNBS-induced control group, #p < 0.05 as compared to sham as well as 
ethanol-treated control group and $p < 0.05 as compared to one another. SLZ (350): TNBS-induced 
and Sulfasalazine (350 mg/kg, p.o.) treated group; FA (10): TNBS-induced and Ferulic acid (10 mg/kg, 
p.o.) treated group; FA (20): TNBS-induced and Ferulic acid (20 mg/kg, p.o.) treated group and FA 
(40): TNBS-induced and Ferulic acid (40 mg/kg, p.o.) treated group. 
 
 
Figure 3: Effect of FA on TNBS-induced alteration in colon histology of rats. Photomicrograph of 
sections of colon of normal group (A), sham control group (B), TNBS-induced control group (C), 
TNBS-induced and Sulfasalazine (350 mg/kg, p.o.) treated group (D), TNBS-induced and FA (20 
mg/kg, p.o.) treated group (E) and TNBS-induced and FA (40 mg/kg, p.o.) treated group (F). Images 
of H&E stain at 40X. Ulceration (black arrow), inflammatory infiltration (yellow arrow) and edema 
(green arrow). 
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Table 3: Effect of FA on TNBS-induced alteration in histology of rat colon 
Treatment 
Mucosal  
epithelium Crypts Lamina propria Submucosa 
Ulceration Mucus deple-tion 
Mononuclear 
infiltrate 
Granulocyte in-
filtrate 
Mononuclear 
infiltrate 
Granulocyte in-
filtrate Oedema 
Sham 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.66 ± 0.33 0.00 ± 0.00 0.66 ± 0.33 0.66 ± 0.33 
Ethanol treated 0.66 ± 0.33 0.00 ± 0.00 0.00 ± 0.00 0.66 ± 0.33 0.66 ± 0.33 0.66 ± 0.33 0.66 ± 0.33 
TNBS-induced Control 2.66 ± 0.33# 1.66 ± 0.88# 1.66 ± 0.88# 2.66 ± 0.33# 1.66 ± 0.88# 1.66 ± 0.88# 2.00 ± 0.57# 
TNBS + Sulfasalazine (350) 1.00 ± 0.00*,$ 0.00 ± 0.00*,$ 0.00 ± 0.00*,$ 0.66 ± 0.33*,$ 0.66 ± 0.33*,$ 0.00 ± 0.00*,$ 0.66 ± 0.33*,$ 
TNBS + FA (10) 2.66 ± 0.33 1.66 ± 0.88 1.33 ± 0.33 1.66 ± 0.88 1.66 ± 0.88 1.33 ± 0.33 1.66 ± 0.88 
TNBS + FA (20) 2.00 ± 0.57 1.33 ± 0.33* 0.66 ± 0.33*,$ 1.33 ± 0.33* 1.33 ± 0.33* 1.33 ± 0.33* 1.66 ± 0.88* 
TNBS + FA (40) 1.00 ± 0.00*,$ 1.00 ± 0.00*,$ 0.66 ± 0.33* 0.66 ± 0.33*,$ 0.00 ± 0.00*,$ 0.00 ± 0.00*,$ 1.33 ± 0.33*,$ 
Data are expressed as mean ± S.E.M. (n = 3) and analyzed by one-way ANOVA followed by Tukey's multiple range test.  
*P < 0.05 as compared to TNBS-induced control group, #P < 0.05 as compared to sham as well as ethanol-treated control group and $P < 0.05 as compared to one another. 
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whereas glutathione (GSH), a non-enzymatic 
antioxidant and both together play a vital 
role in cellular defense against elevated H2O2 
generation (Kandhare et al., 2015a). Fur-
thermore, malondialdehyde (MDA) is a 
highly toxic molecule which is a secondary 
product of lipid peroxidation. Elevated MDA 
level is a reliable and sensitive indicator of 
the severity and extent of increased lipid pe-
roxidation in inflamed colon tissue. In the 
present study, decreased SOD and GSH lev-
els were found in the colonic mucosa of coli-
tis-induced rats which might be due to ex-
cessive free radical production. Treatment 
with FA significantly increased the SOD and 
GSH contents as well as decreased the MDA 
contents in TNBS-induced colitis rats. It may 
be due to the antioxidant potential of FA. 
Other studies also documented this 
antioxidant potential of FA to ameliorate 
ROS-induced damage in various disease 
states (Barros et al., 2008; Ghaisas et al., 
2014). 
Myeloperoxidase (MPO) is an enzymatic 
catalyst stored in azurophilic granules of 
polymorphonuclear neutrophils and macro-
phages. An elevated level of MPO consid-
ered as an indicator of neutrophil activation 
under the influence of pro-oxidative and pro-
inflammatory conditions (Honmore et al., 
2015; Kandhare et al., 2012b). Similarly, we 
also found significantly elevated MPO levels 
in TNBS-induced colitis rats. Under stressful 
conditions, MPO catalyzes the formation of 
cytotoxic oxidants like hypochlorous acid 
from H2O2 and chloride ions (Yamada and 
Grisham, 1991). Reduction in the activity of 
MPO enzyme after FA administration may 
be due to its anti-inflammatory potential. 
This notion is further supported by the 
histological finding of colonic tissue of FA 
treated rats where it effectively reduced the 
histological signs of inflammatory infiltra-
tion, edema, and tissue injury. The anti-
inflammatory effects of FA via inhibition of 
MPO have been previously described (Islam 
et al., 2008). Thus, findings of present inves-
tigation where FA suppressed the severity of 
TNBS colitis via inhibition of MPO activity 
is in line with the result reviewed elsewhere 
(Islam et al., 2008). 
It has been well documented that L-
arginine is a precursor for the synthesis of ni-
tric oxide (NO) via nitric oxide synthase 
(NOs) (Kandhare et al., 2015b). Expression 
of inducible NOs increases under oxidative 
stress conditions (Raygude et al., 2012a). 
NO in association with superoxide anion 
forms a poisonous peroxynitrite (ONOO−) 
anion which activates the nitrosative stress 
and caused dysregulation of inflammatory 
cells function that impairs the colonic muco-
sa (Dijkstra et al., 1998). Interestingly, in the 
present study, we found a significantly ele-
vated colonic mucosal NO activity with up-
regulated expression of iNOS. Administra-
tion of FA resulted in significant down-
regulation of iNOS expression with a 
subsequent decrease in colonic NO level 
which seems to ameliorate the inflammatory 
response and tissue injury in experimental 
colitis.  
Hydroxyproline is an amino acid, and its 
quantification act as an important indicator 
for collagen synthesis (Kandhare et al., 
2015a). In the present study, elevated hy-
droxyproline level was found after TNBS 
administration, and this increased hydroxy-
proline level significantly correlated with the 
accumulated collagen in colonic tissue. The 
results of the present investigation are in line 
with findings of the previous study (Motawi 
et al., 2012). However, FA treatment signifi-
cantly reduced the colonic hydroxyproline 
activity in TNBS-induced colitis rats which 
reflected tissue healing. 
Immune cells hyperactivation plays a 
crucial role in the progression of IBD via the 
release of pro-inflammatory cytokines like 
TNF-α and IL-1β (Rojas-Cartagena et al., 
2005). These elevated levels of pro-
inflammatory cytokines are observed not on-
ly in the inflamed gut of IBD patients but al-
so in animals with TNBS-induced colitis 
(Hyam et al., 2013). Increased TNF-α levels 
cause disruption of the epithelial barrier and 
induces the apoptosis of epithelial cells 
which leads to secretions of chemokines 
EXCLI Journal 2016;15:482-499 – ISSN 1611-2156 
Received: May 17, 2016, accepted: July 07, 2016, published: August 09, 2016 
 
 
495 
from intestinal epithelial cells (Bischoff et 
al., 1999). IL-1β and IL-6 are important for 
gastrointestinal host defense however, their 
overproduction may lead to excessive gut in-
flammation and intestinal motility disorders 
(Bossone et al., 2001). IL-6 is involved in 
recruitment and activation of neutrophils, 
which are believed to be important in exac-
erbations of IBD (Hyam et al., 2013). It has 
been suggested that the infiltration of neu-
trophils into the mucosa significantly con-
tributes to tissue necrosis and dysfunction 
(Grisham et al., 2002). In addition, chemical 
moieties such as TNF-α and IL’s antagonist 
was found to suppress the infiltration of in-
flammatory cells in the colonic tissue in an 
animal model of experimental colitis 
(Tountas et al., 1999). In the current study, 
TNBS significantly elevated colonic mRNA 
expression of TNF-α, IL-1β, and IL-6 which 
may advocates enhanced immune 
inflammatory response. FA administration 
significantly attenuated the upregulated 
TNF-α, IL-1β, and IL-6 colonic mRNA ex-
pression. This immunomodulatory effect of 
FA might be beneficial against intestinal in-
flammation. 
IL-10 is an anti-inflammatory cytokine 
and inhibits the production of pro-
inflammatory cytokines and chemokines in-
cluding TNF-α, IL-1β, and IL-6 (Moore et 
al., 2001). It has been reported that IL-10 re-
ceptor-2 deficient mice exhibit intestinal in-
flammation mediated via T helper (Th)-1 re-
sponse (Berg et al., 1996) which reflects the 
important role of IL-10 in the regulation of 
cytokine expression in the mucosal immune 
system. Previous research has shown that 
TNBS-induced colitis is associated with de-
creased level of IL-10 in colon homogenates 
(Hyam et al., 2013). Results of the present 
investigation are accordance with the find-
ings previously study (Hyam et al., 2013). 
Moreover, FA treatment significantly de-
creased the TNBS-induced down-regulation 
of intestinal IL-10 mRNA expression. This 
effect might be due to the anti-inflammatory 
activity of FA. 
It has been well documented that Cy-
clooxygenase-2 (COX-2) is an inducible iso-
form of cyclooxygenase which serves as the 
rate-limiting enzyme and catalyzes the initial 
step of arachidonic acid metabolic transfor-
mation into prostanoids. Elevated levels of 
inducible enzyme COX-2 has been reported 
at the sites of inflammation during experi-
mental colitis (de Faria et al., 2012). Over-
production of TNF-α and nitric oxide (NO) 
association with COX-2 cause cellular de-
generation in the inflamed colon (Kim et al., 
2005). Thus, elevated pro-inflammatory in-
flux after TNBS administration caused 
elevated levels of COX-2 and iNOS, which 
was reversed by the FA treatment due to its 
anti-inflammatory potential. The results of 
present investigations are in line with the 
previous study, where FA inhibits protein 
expression of COX-2 and iNOS (Ojha et al., 
2015). 
Apoptosis is a programmed cell death 
occurring in various inflammatory diseases 
including IBD (Wang et al., 2015). It indi-
cated a rapid switch from the inflammatory 
phase to the proliferative phase. In the 
present investigation, flow cytometric evalu-
ation of colonic tissue from TNBS-induced 
control rats showed significantly increased 
apoptotic and necrotic cells in upper quad-
rants. The elevated apoptosis occurred due to 
rapid production and release of a pro-
inflammatory cytokine such as TNF-α, 
which is responsible for tissue apoptosis 
(Kandhare et al., 2014; Raygude et al., 
2012b). Treatment with FA significantly re-
duced the cell apoptosis, as reflected by the 
decreased percentage of necrotic cells as 
compared to TNBS-induced control rats. 
Recently, it has been shown that CAM 
therapy is used as an adjuvant therapy along 
with conventional therapy in 40 % of pa-
tients with IBD (Hilsden et al., 2011). A ran-
domized, double-blind, placebo-controlled 
study showed that wheatgrass juice (Triticum 
aestivum), aloe vera gel and Andrographis 
paniculata extract (HMPL-004) were superi-
or to placebo (Ben-Arye et al., 2002; 
Langmead et al., 2004; Sandborn et al., 
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2013). Furthermore, eighty-nine patients 
with UC randomized to curcumin (1 g twice 
daily) showed significantly lower relapse 
rate than the placebo group (Hanai et al., 
2006). Administration of Boswellia serrata 
(900 mg daily) showed an improvement in 
stool properties, histopathology, and scan-
ning electron microscopy (Gupta et al., 
2001). Plantago ovata seeds also showed a 
promising effect in reduction and preventing 
clinical recurrence of postoperative IBD 
(Fernandez-Banares et al., 1999). 
It has been documented that the polyphe-
nol compound that possesses one hydroxyl 
group in the aromatic ring seemed to have 
potent antioxidant activity (Nenadis et al., 
2003). Moreover, the presence of electron-
donating groups attached to the aromatic ring 
such as –OCH3 and –OH ought to increase 
free radical scavenging potential. The 
presence of electron-donating –OH groups 
attached to the para or 4-position of the aro-
matic ring in FA owing to a greater number 
of canonical resonance that eventually con-
tribute to its antioxidant property (Karamac 
et al., 2005). Furthermore, previous mole-
cular docking study of FA with Cyclooxyge-
nase-2 showed that it forms dimer via the 
formation of a strong hydrogen bond 
between –OH of –COOH group of one FA 
molecule with the oxygen atom of the C = O 
group of adjacent molecule to serves as 
potent inhibitors of COX-2 enzyme (Kumar 
and Pruthi, 2015). 
Sulfasalazine (SLZ) is a sulfa drug cur-
rently used for the treatment of human IBD. 
It is poorly absorbed in the gut but, its me-
tabolite 5-aminosalicylic acid has been effec-
tive against colitis (Horvath et al., 2008). An 
array of evidence suggests that SLZ reduces 
inflammation by various mechanisms includ-
ing inhibition of cyclooxygenase and 5-
lipoxygenase pathway of arachidonic acid 
metabolism (Horvath et al., 2008; Witaicenis 
et al., 2012). In the present study, admin-
istration of SLZ (350 mg/kg) as well as FA 
(20 and 40 mg/kg) reduced the number of in-
testinal epithelial cell apoptotic damage via 
different mechanisms including inhibition of 
colonic oxidative stress, the release of pro-
inflammatory mediators and COX-2. Thus, it 
is possible that the inhibitory effect of FA or 
SLZ on these mediators could be compara-
ble, at least in part, to inhibit TNBS-induced 
colitis. 
Thus, anti-inflammatory activity exhibit-
ed by FA in the TNBS-induced colitis can be 
attributed to its ability to inhibit oxido-
nitrosative stress, apoptosis, proinflammato-
ry cytokines production, and down- regula-
tion of COX-2 synthesis. 
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